[1] |
Wong VK, Turmezei TD, Weston VC. Actinomycosis[J]. BMJ, 2011,343:d6099. doi: 10.1136/bmj.d6099.
|
[2] |
Könönen E, Wade WG. Actinomyces and related organisms in human infections[J]. Clin Microbiol Rev, 2015,28(2):419⁃442. doi: 10.1128/CMR.00100⁃14.
|
[3] |
Sabbe LJ, Van De Merwe D, Schouls L, et al. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus[J]. J Clin Microbiol, 1999, 37(1):8⁃13.
|
[4] |
Cobo F. Breast abscess due to Actinomyces turicensis in a non⁃puerperal woman[J]. Enferm Infecc Microbiol Clin, 2018,36(6):388⁃389. doi: 10.1016/j.eimc.2017.09.014.
|
[5] |
李颖, 彭涛, 王凯, 等. 剖宫产术后复杂性腹腔感染合并苏黎世放线菌感染一例[J]. 临床医药文献电子杂志, 2018,5(68):168⁃169. doi: 10.3877/j.issn.2095⁃8242.2018.68.098.
|
[6] |
刘岩, 蒲增惠, 赵茂茂, 等. 耳廓苏黎世放线菌病首例报告及文献复习[J]. 中国感染控制杂志, 2019,18(1):79⁃82. doi: 10.12138/j.issn.1671⁃9638.20194024.
|
[7] |
Moreno C, Romero J, Espejo RT. Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus Vibrio[J]. Microbiology, 2002,148(Pt 4):1233⁃1239. doi: 10.1099/00221287⁃148⁃4⁃1233.
|
[8] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100S[S]. Wayne, PA: Clinical and Laboratory Standards Institute, 2016.
|
[9] |
Filipović B, Milinić N, Nikolić G, et al. Primary actinomycosis of the anterior abdominal wall: case report and review of the literature[J]. J Gastroenterol Hepatol, 2005,20(4):517⁃520. doi: 10.1111/j.1440⁃1746.2004.03564.x.
|
[10] |
Gatti M, Gasparini LE, Grimaldi CM, et al. Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literature[J]. J Chemother, 2017,29(6):372⁃375. doi: 10.1080/1120009X.2017. 1306154.
|
[11] |
Fazili T, Blair D, Riddell S, et al. Actinomyces meyeri infection: case report and review of the literature[J]. J Infect, 2012,65(4): 357⁃361. doi: 10.1016/j.jinf.2012.02.016.
|
[12] |
王立, 刘正印, 王爱霞. 放线菌病九例临床分析[J]. 中华内科杂志, 2007,46(5):389⁃391. doi: 10.3760/j.issn:0578⁃1426.2007. 05.014.
|
[13] |
Pulverer G, Schütt⁃Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases[J]. Clin Infect Dis, 2003,37(4):490⁃497. doi: 10.1086/376621
|
[14] |
Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases[J]. Laryngoscope, 1984,94(9):1198⁃1217. doi: 10.1288/00005537⁃198409000⁃00013.
|
[15] |
Barberis C, Budia M, Palombarani S, et al. Antimicrobial susceptibility of clinical isolates of Actinomyces and related genera reveals an unusual clindamycin resistance among Actinomyces urogenitalis strains[J]. J Glob Antimicrob Resist, 2017,8:115⁃120. doi: 10.1016/j.jgar.2016.11.007.
|
[16] |
Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species[J]. J Antimicrob Chemother, 2016,71(2):422⁃427. doi: 10.1093/jac/dkv347.r.
|